• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国有超重和肥胖问题的参加私人保险的员工的工作损失情况。

Work loss among privately insured employees with overweight and obesity in the United States.

作者信息

Shinde Shraddha, Tran Anh Thu, Jerry Michelle, Lee Clare J

机构信息

Eli Lilly and Company Indianapolis Indiana USA.

Merative Ann Arbor Michigan USA.

出版信息

Obes Sci Pract. 2024 Jul 8;10(4):e775. doi: 10.1002/osp4.775. eCollection 2024 Aug.

DOI:10.1002/osp4.775
PMID:38979094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11229424/
Abstract

BACKGROUND

Rising obesity rates in the workforce are accompanied by a hidden cost burden to employers due to work productivity loss. Understanding the impact of obesity on work productivity is essential for employers to provide tailored weight loss interventions in the workplace.

OBJECTIVES

To measure work loss and associated productivity costs among employees with overweight/obesity compared with employees with normal weight.

METHODS

This retrospective cohort study used the Merative MarketScan® Health and Productivity Management Database to identify adult employees with ≥1 diagnosis code reporting a body mass index (BMI) between 1/1/2015-12/31/2019. Based on the earliest BMI, employees were assigned to normal weight (BMI 19-24.9), overweight (BMI 25-29.9), obesity class 1 (BMI 30-34.9), obesity class 2 (BMI 35-39.9), and obesity class 3 (BMI ≥40) cohorts. Among employees with data for each work loss category (absenteeism, short-term disability [STD], long-term disability [LTD], worker's compensation [WC]) during the 12-month follow-up, the percentage of employees with work loss, number of hours/days lost, and associated productivity costs were reported.

RESULTS

719,482 employees (normal weight: 106,631, overweight: 230,637, obesity class 1: 185,850, obesity class 2: 101,909, obesity class 3: 94,455) were included. Outcomes increased with each higher BMI category for the mean number of absence hours ([in order of BMI category]: 262, 273, 285, 290, 304) and percentage of employees with a claim (STD: 6.8%, 7.6%, 9.7%, 11.7%, 17.0%; LTD: 0.4%, 0.4%, 0.5%, 0.6%, 0.8%; WC: 2.7%, 2.8%, 3.4%, 3.6%, 3.5%). Estimated costs to the employer associated with absenteeism, STD, LTD, and WC were $1,036, $611, $38, and $95 higher per year (respectively) in the obesity class 3 cohort relative to the normal weight cohort.

CONCLUSIONS

This real-world analysis demonstrated that employees with overweight/obesity had higher loss of work productivity compared with employees with normal weight. Further studies are warranted to determine the long-term impacts on work productivity loss if overweight and obesity are left untreated.

摘要

背景

劳动力中肥胖率的上升伴随着雇主因工作效率损失而承担的隐性成本负担。了解肥胖对工作效率的影响对于雇主在工作场所提供量身定制的减肥干预措施至关重要。

目的

测量超重/肥胖员工与正常体重员工相比的工作损失及相关的生产力成本。

方法

这项回顾性队列研究使用了默克多市场扫描健康与生产力管理数据库,以识别在2015年1月1日至2019年12月31日期间有≥1个诊断代码报告体重指数(BMI)的成年员工。根据最早的BMI,员工被分配到正常体重(BMI 19 - 24.9)、超重(BMI 25 - 29.9)、1级肥胖(BMI 30 - 34.9)、2级肥胖(BMI 35 - 39.9)和3级肥胖(BMI≥40)队列。在12个月随访期间有每个工作损失类别(旷工、短期残疾[STD]、长期残疾[LTD]、工伤赔偿[WC])数据的员工中,报告了有工作损失的员工百分比、损失的小时数/天数以及相关的生产力成本。

结果

纳入了719,482名员工(正常体重:106,631名,超重:230,637名,1级肥胖:185,850名,2级肥胖:101,909名,3级肥胖:94,455名)。随着BMI类别升高,平均缺勤小时数(按BMI类别顺序)以及有索赔的员工百分比的结果均增加(平均缺勤小时数:262、273、285、290、304;STD索赔:6.8%、7.6%、9.7%、11.7%、17.0%;LTD索赔:0.4%、0.4%、0.5%、0.6%、0.8%;WC索赔:2.7%、2.8%、3.4%、3.6%、3.5%)。与正常体重队列相比,3级肥胖队列中雇主因旷工、STD、LTD和WC每年产生的估计成本分别高出1,036美元、611美元、38美元和95美元。

结论

这项实际分析表明,超重/肥胖员工与正常体重员工相比,工作效率损失更高。如果超重和肥胖得不到治疗,对工作效率损失的长期影响如何,还有待进一步研究确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/2b329b5ef3ee/OSP4-10-e775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/ff43c4a0f8c7/OSP4-10-e775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/b5ada0f492db/OSP4-10-e775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/4159569866cd/OSP4-10-e775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/39f3aa01795a/OSP4-10-e775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/2b329b5ef3ee/OSP4-10-e775-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/ff43c4a0f8c7/OSP4-10-e775-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/b5ada0f492db/OSP4-10-e775-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/4159569866cd/OSP4-10-e775-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/39f3aa01795a/OSP4-10-e775-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6033/11229424/2b329b5ef3ee/OSP4-10-e775-g002.jpg

相似文献

1
Work loss among privately insured employees with overweight and obesity in the United States.美国有超重和肥胖问题的参加私人保险的员工的工作损失情况。
Obes Sci Pract. 2024 Jul 8;10(4):e775. doi: 10.1002/osp4.775. eCollection 2024 Aug.
2
Impact of COVID-19 on work loss in the United States- A retrospective database analysis.2019冠状病毒病对美国工作损失的影响——一项回顾性数据库分析
J Med Econ. 2024 Jan-Dec;27(1):941-951. doi: 10.1080/13696998.2024.2379056. Epub 2024 Jul 18.
3
Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.美国胆管癌患者的生产力损失结果及成本:一项经济学评估
J Med Econ. 2023 Jan-Dec;26(1):454-462. doi: 10.1080/13696998.2023.2187604.
4
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.基于网络的项目对学龄儿童肥胖症减轻的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248.
5
Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.队列分析评估工作场所肥胖相关的医疗和非医疗成本。
J Occup Environ Med. 2014 Feb;56(2):161-70. doi: 10.1097/JOM.0000000000000099.
6
A multi-worksite analysis of the relationships among body mass index, medical utilization, and worker productivity.多工作场所分析体重指数、医疗利用和工人生产力之间的关系。
J Occup Environ Med. 2010 Jan;52 Suppl 1(Suppl 1):S52-8. doi: 10.1097/JOM.0b013e3181c95b84.
7
Productivity loss and productivity loss costs to United States employers due to priority conditions: a systematic review.由于优先级条件导致美国雇主的生产力损失和生产力损失成本:系统评价。
J Med Econ. 2023 Jan-Dec;26(1):262-270. doi: 10.1080/13696998.2023.2172282.
8
The association between employee obesity and employer costs: evidence from a panel of U.S. employers.员工肥胖与雇主成本之间的关联:来自美国雇主样本的证据。
Am J Health Promot. 2014 May-Jun;28(5):277-85. doi: 10.4278/ajhp.120905-QUAN-428.
9
Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.与心血管事件及相关临床程序相关的生产力损失和间接成本。
BMC Health Serv Res. 2015 Jun 25;15:245. doi: 10.1186/s12913-015-0925-x.
10
Economic value of nonsurgical weight loss in adults with obesity.肥胖成年人非手术减肥的经济价值。
J Manag Care Spec Pharm. 2021 Jan;27(1):37-50. doi: 10.18553/jmcp.2020.20036. Epub 2020 Nov 9.

引用本文的文献

1
Assessing the economic impact of obesity and overweight on employers: identifying opportunities to improve work force health and well-being.评估肥胖和超重对雇主的经济影响:确定改善劳动力健康和福祉的机会。
Nutr Diabetes. 2024 Dec 4;14(1):96. doi: 10.1038/s41387-024-00352-9.

本文引用的文献

1
Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.美国退伍军人参与 MOVE!体重管理计划的抗肥胖药物的临床和成本效益。
Popul Health Manag. 2023 Feb;26(1):72-82. doi: 10.1089/pop.2022.0227. Epub 2023 Feb 3.
2
The Relative Value of Anti-Obesity Medications Compared to Similar Therapies.与类似疗法相比,抗肥胖药物的相对价值。
Clinicoecon Outcomes Res. 2023 Jan 26;15:51-62. doi: 10.2147/CEOR.S392276. eCollection 2023.
3
A review of current guidelines for the treatment of obesity.
肥胖治疗当前指南述评。
Am J Manag Care. 2022 Dec;28(15 Suppl):S288-S296. doi: 10.37765/ajmc.2022.89292.
4
Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.抗肥胖药物联合雇主为基础的体重管理计划治疗肥胖的效果:一项随机临床试验。
JAMA Netw Open. 2021 Jul 1;4(7):e2116595. doi: 10.1001/jamanetworkopen.2021.16595.
5
Direct medical costs of obesity in the United States and the most populous states.美国和人口最多的州的肥胖直接医疗成本。
J Manag Care Spec Pharm. 2021 Mar;27(3):354-366. doi: 10.18553/jmcp.2021.20410. Epub 2021 Jan 20.
6
Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.按体重指数细分的 13 种肥胖相关并发症的特定并发症直接医疗费用:一项回顾性数据库研究。
J Manag Care Spec Pharm. 2021 Feb;27(2):210-222. doi: 10.18553/jmcp.2020.20272. Epub 2020 Dec 14.
7
Direct and Indirect Cost of Obesity Among the Privately Insured in the United States: A Focus on the Impact by Type of Industry.美国私人保险中肥胖的直接和间接成本:重点关注行业类型的影响。
J Occup Environ Med. 2019 Nov;61(11):877-886. doi: 10.1097/JOM.0000000000001693.
8
Impact of Obesity on Work Productivity in Different US Occupations: Analysis of the National Health and Wellness Survey 2014 to 2015.肥胖对美国不同职业工作效率的影响:2014 至 2015 年全国健康与健康调查分析。
J Occup Environ Med. 2018 Jan;60(1):6-11. doi: 10.1097/JOM.0000000000001144.
9
Productivity loss due to overweight and obesity: a systematic review of indirect costs.超重和肥胖导致的生产力损失:间接成本的系统评价
BMJ Open. 2017 Oct 5;7(10):e014632. doi: 10.1136/bmjopen-2016-014632.
10
Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis.估算美国肥胖症的医疗费用:系统评价、荟萃分析与实证分析。
Value Health. 2016 Jul-Aug;19(5):602-13. doi: 10.1016/j.jval.2016.02.008. Epub 2016 Apr 6.